Exact Sciences Corporation
EXASNASDAQ
USReal-Time Price
USReal-Time Price$104.91USD
0.00 (0.00%)Today
BTI Score
Near Future
50
Long Term
55
BTI Fair Market Cap
$4.51B
+343.80% vs fair
Healthcare & Pharma
High Risk
Exact Sciences Corporation (EXAS) Earnings
Exact Sciences Corporation (EXAS) earnings: next report date, EPS and revenue consensus, historical surprises and the full quarterly results timeline.
Earnings Trends
Earnings Per Share
Revenue Beat Rate
89%
Beat
8Meet
0Miss
1Total
9EPS Beat Rate
0%
Beat
0Meet
0Miss
0Total
0Earnings Consistency
0%
Both Beat
0Other
0Total
0Quarterly EPS Performance
Recent results and upcoming quarter
Q2 FY26
30 / 06 / 2026
Estimate—
Actual—
Surprise—
Q1 FY26
31 / 03 / 2026
Estimate—
Actual—
Surprise—
Q4 FY25
31 / 12 / 2025
Estimate—
Actual—
Surprise—
Next Quarter
TBD
Estimate—
Actual—
Surprise—
Revenue vs Earnings Over Time
Revenue (B USD)
Net Income (B USD)
Profit Margin (%)
EPS: Estimate vs Reported
Earnings History
| Quarter | EPS Est. | Reported EPS | Surprise | Rev. Est. | Reported Rev. | Date |
|---|---|---|---|---|---|---|
| Q2 FY26 | — | — | —▼ Miss | $934.35M | — | 30 / 06 / 2026 |
| Q1 FY26 | — | — | —▼ Miss | $846.38M | — | 31 / 03 / 2026 |
| Q4 FY25 | — | — | —▼ Miss | $860.59M | $878.38M | 31 / 12 / 2025 |
| Q3 FY25 | — | — | —▼ Miss | $810.42M | $850.74M | 30 / 09 / 2025 |
| Q2 FY25 | — | — | —▼ Miss | $774.43M | $811.09M | 30 / 06 / 2025 |
| Q1 FY25 | — | — | —▼ Miss | $688.58M | $706.78M | 31 / 03 / 2025 |
| Q4 FY24 | — | — | —▼ Miss | $701.45M | $713.42M | 31 / 12 / 2024 |
| Q3 FY24 | — | — | —▼ Miss | $716.80M | $708.66M | 30 / 09 / 2024 |
| Q2 FY24 | — | — | —▼ Miss | $690.02M | $699.26M | 30 / 06 / 2024 |
| Q1 FY24 | — | — | —▼ Miss | $624.95M | $637.52M | 31 / 03 / 2024 |
| Q4 FY23 | — | — | —▼ Miss | $638.83M | $646.89M | 31 / 12 / 2023 |
Source: FMP Earnings Calendar API. Surprise = (Actual − Estimate) / |Estimate| × 100.
EXAS upcoming earnings call
Date not announced yet
Coming Soon